Psoriasis and Cardiovascular Risk: Strength in Numbers Part 3

Journal of Investigative Dermatology

Volumn 135, Issue 9, 2015, Pages 2148-2150

  Ogdie, Alexis ^a   Troxel, Andrea B ^a   Mehta, Nehal N ^a   Gelfand, Joel M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; COMPUTER ASSISTED TOMOGRAPHY; DISEASE DURATION; DISEASE SEVERITY; FOLLOW UP; HUMAN; MEDICAL RECORD; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSORIASIS; REVIEW; SMOKING; CARDIOVASCULAR DISEASES; FEMALE; MALE;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; MALE; PSORIASIS;

EID: 84939422581     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2015.218     Document Type: Note

References (20)

1. Armstrong AW, Harskamp CT, Ledo L et al. (2012) Coronary artery disease in patients with psoriasis referred for coronary angiography. Am J Cardiol 109:976-80
2. Dregan A, Charlton J, Chowienczyk P et al. (2014) Chronic inflammatory disorders and risk of type 2 diabetes mellitus, coronary heart disease, and stroke: a population-based cohort study. Circulation 130:837-44
3. Fisher RA (1926) The arrangement of field experiments. J Min Agric Gr Br 33:503-13
4. Gelfand JM, Dommasch ED, Shin DB et al. (2009) The risk of stroke in patients with psoriasis. J Invest Dermatol 129:2411-8
5. Gelfand J, Neimann A, Shin D et al. (2006) Risk of myocardial infarction in patients with psoriasis. JAMA 296:1735-42
6. Gelfand JM, Azfar RS, Mehta NN (2010) Psoriasis and cardiovascular risk: strength in numbers. J Invest Dermatol 130:919-22
7. Gelfand JM, Mehta NN, Langan SM(2011) Psoriasis and cardiovascular risk: strength in numbers, part II. J Invest Dermatol 131:1007-10
8. Goodman S (2008) A dirty dozen: twelve p-value misconceptions. Semin Hematol 45:135-40
9. Greenland S, Rothman KJ, Lash TL (2008) Measures of effect and measures of association. In Modern epidemiology In: Rothman KJ, Greenland S, Lash T (eds). Lippincott, Williams & Wilkins: Philadelphia, PA, USA, 51-70
10. Hennekens CH, Buring JE (1987) Analysis of epidemiology studies: evaluating the role of confounding. Mayrent SL (ed). Epidemiology in Medicine. Little, Brown and Company: Boston, MA, USA, 287-323
11. Li WQ, Han JL, Manson JE et al. (2012) Psoriasis and risk of nonfatal cardiovascular disease in U.S. women: a cohort study. Br J Dermatol 166:811-8
12. Masuda H, Miyazaki T, Shimada K et al. (2014) Disease duration and severity impacts on longterm cardiovascular events in japanese patients with rheumatoid arthritis. J Cardiol 64: 366-70
13. Mehta NN, Azfar RS, Shin DB et al. (2010) Patients with severe psoriasis are at increased risk of cardiovascular mortality: Cohort study using the general practice research database. Eur Heart J 31:1000-6
14. Mehta NN, Li R, Krishnamoorthy P et al. (2012) Abnormal lipoprotein particles and cholesterol efflux capacity in patients with psoriasis. Atherosclerosis 224:218-21
15. Mehta NN, Yu Y, Saboury B et al. (2011) Systemic and vascular inflammation in patients with moderate to severe psoriasis as measured by [18F]-fluorodeoxyglucose positron emission tomography-computed tomography (FDG-PET/CT): a pilot study. Arch Dermatol 147:1031-9
16. Ogdie A, Yu Y, Haynes K et al. (2015) Risk of major cardiovascular events in patients with psoriatic arthritis, psoriasis and rheumatoid arthritis: a population-based cohort study. Ann Rheum Dis 74:326-32
17. Parisi R, Rutter MK, Lunt M et al. (2015) Psoriasis and the risk of major cardiovascular events: Cohort study using the clinical practice research datalink. J Invest Dermatol 135:2189-97
18. Ridker PM (2010) Psoriasis, inflammation, and vascular risk: a problem more than skin deep? Eur Heart J 31:902-4
19. Roubille C, Richer V, Starnino T et al. (2015) The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-Analysis. Ann Rheum Dis 74: 480-9.
20. Takeshita J, Wang S, Shin DB et al. (2015) Effect of psoriasis severity on hypertension control: a population-based study in the United Kingdom. JAMA Dermatol 151:161-9